TRVI:NASDAQ
Trevi Therapeutics Inc
$13.61
arrow_upward
+0.81%(+0.11) 1D
Jun 9, 10:22:08 AM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TRVI...
Open
$13.65
High
$13.89
Low
$13.50
Mkt. cap
1.96B
Avg. vol.
1.30M
Volume
123.35K
52-wk high
$16.12
52-wk low
$5.41
EPS
-$0.32
Beta
1.04
Shares outstanding
141.98M
No. of employees
34
Open
$13.65
High
$13.89
Low
$13.50
Mkt. cap
1.96B
Avg. vol.
1.30M
Volume
123.35K
52-wk high
$16.12
52-wk low
$5.41
EPS
-$0.32
Beta
1.04
Shares outstanding
141.98M
No. of employees
34
Analyst outlook
Analyst Ratings
Based on 8 analysts giving stock ratings to TRVI in the past 3 months
Strong Buy
Buy
8
Hold
0
Sell
0
12 month forecast
Based on 8 Wall Street analysts offering 12 month price targets for TRVI in the last 3 months.
Highest
Current $13.61
$30.00 (+120.43%)
Average
$24.50 (+80.01%)
Lowest
$20.00 (+46.95%)
News stories
From sources across the web
Simply Wall Street
·
11 hours ago
Assessing Trevi Therapeutics (TRVI) Valuation After Recent Share Price Pullback And Haduvio Expectations
About Trevi Therapeutics Inc
CEO-
Employees34
Founded2011
HeadquartersNew Haven, Connecticut, United States
SectorPharmaceutical industry
Websitetrevitherapeutics.com
AI content may include mistakes. Learn more